HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piet van Riel Selected Research

sirukumab

6/2017EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Piet van Riel Research Topics

Disease

13Rheumatoid Arthritis
09/2022 - 04/2003
4Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 05/2012
4Rheumatic Diseases (Rheumatism)
01/2021 - 12/2003
3Necrosis
06/2017 - 06/2010
2Pain (Aches)
01/2018 - 04/2003
2Inflammation (Inflammations)
05/2012 - 01/2008
1Hypertension (High Blood Pressure)
01/2021
1Diabetes Mellitus
01/2021
1Gout
12/2017
1Vasculitis (Vasculitides)
08/2016
1Myositis (Idiopathic Inflammatory Myopathies)
08/2016
1Spondylarthropathies
08/2016
1Connective Tissue Diseases (Connective Tissue Disease)
08/2016
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2016
1Sarcoidosis (Schaumann Disease)
08/2016
1Weight Loss (Weight Reduction)
07/2014
1Infections
06/2010
1Neoplasms (Cancer)
06/2010
1Fever (Fevers)
01/2008

Drug/Important Bio-Agent (IBA)

4Antirheumatic Agents (DMARD)IBA
01/2021 - 06/2010
4Methotrexate (Mexate)FDA LinkGeneric
06/2017 - 02/2007
3LipidsIBA
09/2022 - 07/2014
3Biological ProductsIBA
01/2021 - 06/2010
3Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2018 - 04/2003
2GlucocorticoidsIBA
01/2021 - 06/2017
2Sulfasalazine (Azulfidine)FDA LinkGeneric
06/2017 - 06/2012
2Leflunomide (Arava)FDA LinkGeneric
06/2017 - 12/2003
2Etanercept (Enbrel)FDA Link
06/2017 - 07/2007
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1Uric Acid (Urate)IBA
12/2017
1Allopurinol (Remid)FDA LinkGeneric
12/2017
1Abatacept (Orencia)FDA Link
06/2017
1baricitinibIBA
06/2017
1clazakizumabIBA
06/2017
1tofacitinibIBA
06/2017
1tocilizumab (atlizumab)FDA Link
06/2017
1golimumabFDA Link
06/2017
1sirukumabIBA
06/2017
1Certolizumab PegolFDA Link
06/2017
1Adalimumab (Humira)FDA Link
06/2017
1Rituximab (Mabthera)FDA Link
06/2017
1Infliximab (Remicade)FDA Link
06/2017
1sarilumabIBA
06/2017
1Janus Kinase InhibitorsIBA
06/2017
1Tumor Necrosis Factor InhibitorsIBA
06/2017
1Janus KinasesIBA
06/2017
1Biosimilar PharmaceuticalsIBA
06/2017
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
08/2016
1HDL LipoproteinsIBA
05/2012
1HDL CholesterolIBA
05/2012
1Interferon Regulatory FactorsIBA
01/2011
1Azathioprine (Imuran)FDA LinkGeneric
06/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2010
1canakinumabFDA Link
01/2008
1Monoclonal AntibodiesIBA
01/2008
1CytokinesIBA
01/2008
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2008
1amsonic acid (DAS)IBA
12/2003
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2003
1Ro 45-2081IBA
04/2003
1Proteins (Proteins, Gene)FDA Link
04/2003
1Immunoglobulin G (IgG)IBA
04/2003

Therapy/Procedure

4Therapeutics
01/2021 - 07/2014
1Secondary Prevention
01/2021